CLINICAL TRIALS PROFILE FOR SUZETRIGINE
✉ Email this page to a colleague
All Clinical Trials for Suzetrigine
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT06176196 ↗ | Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) | Recruiting | Vertex Pharmaceuticals Incorporated | Phase 2 | 2023-12-13 | The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR. |
| NCT06336096 ↗ | A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine | COMPLETED | Vertex Pharmaceuticals Incorporated | PHASE1 | 2024-03-28 | The purpose of this study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ; VX-548) and its metabolite along with its safety and tolerability, in healthy participants. |
| NCT06628908 ↗ | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | Vertex Pharmaceuticals Incorporated | PHASE3 | 2024-10-01 | The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN). |
| NCT06696443 ↗ | Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) | ENROLLING_BY_INVITATION | Vertex Pharmaceuticals Incorporated | PHASE3 | 2024-12-18 | The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Suzetrigine
Condition Name
Clinical Trial Locations for Suzetrigine
Trials by Country
Clinical Trial Progress for Suzetrigine
Clinical Trial Phase
Clinical Trial Sponsors for Suzetrigine
Sponsor Name
